An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope

Anthony Barnett; M Dreyer; P Lange; M Serdarevic-Pehar

doi:10.2337/dc-06-1466

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope

Anthony Barnett
, M Dreyer
, P Lange
, M Serdarevic-Pehar

Birmingham Medical School

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	2333-2334
Number of pages	2
Journal	Diabetes Care
Volume	29
Issue number	10
DOIs	https://doi.org/10.2337/dc-06-1466
Publication status	Published - 1 Oct 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2337/dc-06-1466

Cite this

Barnett, A., Dreyer, M., Lange, P., & Serdarevic-Pehar, M. (2006). An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope. Diabetes Care, 29(10), 2333-2334. https://doi.org/10.2337/dc-06-1466

@article{1a81ce73c8b6437a8d540af5320e3ffb,

title = "An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope",

author = "Anthony Barnett and M Dreyer and P Lange and M Serdarevic-Pehar",

year = "2006",

month = oct,

day = "1",

doi = "10.2337/dc-06-1466",

language = "English",

volume = "29",

pages = "2333--2334",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "10",

}

Barnett, A, Dreyer, M, Lange, P & Serdarevic-Pehar, M 2006, 'An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope', Diabetes Care, vol. 29, no. 10, pp. 2333-2334. https://doi.org/10.2337/dc-06-1466

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope. / Barnett, Anthony; Dreyer, M; Lange, P et al.
In: Diabetes Care, Vol. 29, No. 10, 01.10.2006, p. 2333-2334.

Research output: Contribution to journal › Article

TY - JOUR

T1 - An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope

AU - Barnett, Anthony

AU - Dreyer, M

AU - Lange, P

AU - Serdarevic-Pehar, M

PY - 2006/10/1

Y1 - 2006/10/1

U2 - 10.2337/dc-06-1466

DO - 10.2337/dc-06-1466

M3 - Article

SN - 0149-5992

VL - 29

SP - 2333

EP - 2334

JO - Diabetes Care

JF - Diabetes Care

IS - 10

ER -

Barnett A, Dreyer M, Lange P, Serdarevic-Pehar M. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope. Diabetes Care. 2006 Oct 1;29(10):2333-2334. doi: 10.2337/dc-06-1466